Antioxidant 1 in hypertension: more than just a copper chaperone.
Antioxidant 1 in hypertension: more than just a copper chaperone.
复制标题
高血压中的抗氧化剂 1:不仅仅是铜伴侣。
DOI:
10.1161/hypertensionaha.112.191304
复制
发表时间:
2012
期刊:
影响因子:
--
通讯作者:
Didion,SeanP
中科院分区:
文献类型:
--
作者:
Didion,SeanP
Oxidative stress, defined as an increase in reactive oxygen species, has been implicated in a number of diseases, including hypertension. Superoxide is a particularly detrimental reactive oxygen species in the cardiovascular system because it reacts directly with NO, thereby limiting the amount of NO normally available for processes such as endothelium-dependent relaxation. Superoxide dismutases (SODs) represent a first-line defense against oxidative stress by tempering increases in superoxide via its metabolism (dismutation).Three distinct mammalian isoforms of SOD exist, CuZn-SOD (localized mainly to the cytoplasmic space), MnSOD (the predominant isoform in mitochondria), and extracellular SOD (SOD3), a CuZnSOD found exclusively in the extracellular compartment (Figure). 1 The fact that there are 3 different gene products that catalyze the same reaction underscores the importance of limiting cellular superoxide. Both CuZnSOD and SOD3 require copper for full catalytic activity; however, free copper is essentially nonexistent (1 copper ion per cell copper). 2 Thus, copper-containing enzymes are dependent on a number of proteins, including copper transporters, copper scavengers, and copper “chaperones” for appropriate delivery of copper. 3 To date, 2 mammalian copper chaperones have been identified, copper chaperone for CuZnSOD delivers copper as its name would imply to CuZnSOD, whereas antioxidant 1 (Atox1) delivers copper to the transgolgi network and SOD3. 4 Although oxidative stress reflects both production and metabolism of superoxide, a majority of studies have focused primarily on those enzymes that produce superoxide, most notably NADPH oxidase. In contrast, no previous studies have considered the relationship between Atox1 and SOD3 expression/activity in hypertension. In this issue of Hypertension, Ozumi et al5 provide some of the first data regarding the role of Atox-1 in limiting hypertension and endothelial dysfunction produced by angiotensin II (Ang II). The authors found that acute (7-day) Ang II infusion was associated with a selective increase in vascular SOD3 expression and activity